Enable Medicine

Insights powered by AI for your next therapeutic breakthrough

Menlo Park, United States · Founded 2019 · $60.0M raised

Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$60.0M
Last Round
$60.0M Series AApr 2022
Rounds
2

About

Enable Medicine is an AI-powered biodata infrastructure company that builds comprehensive biological atlases and cloud-based platforms to accelerate drug discovery and therapeutic development. The company integrates multimodal biological data — including single-cell genomics, spatial biology, and clinically relevant metadata — into searchable, AI-driven maps of human disease that help biopharma companies and academic researchers identify drug targets, stratify patients, and make indication selection decisions. Enable Medicine's platform has indexed over 60,000 samples and more than 1.32 billion cells, and the company collaborates with over 200 active biopharma and academic partners.

Summary

Enable Medicine is an Artificial Intelligence company based in Menlo Park, United States, founded in 2019. It has raised $60.0M in total across 2 rounds, most recently a $60.0M Series A round in Apr 2022. Investors include Anthos Capital, General Catalyst and Breyer Capital.

Tech & App Stack

5 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries AApr 2022
$60.0M

Sign up to see all 2 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies